We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$445M
AUM Growth
+$27.4M
(+6.6%)
Cap. Flow
-$6.37M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
42.16%
Holding
54
New
1
Increased
–
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$4.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$3.38M |
| 2 |
Norfolk Southern
NSC
|
+$2.63M |
| 3 |
International Flavors & Fragrances
IFF
|
+$1.4M |
| 4 |
Pfizer
PFE
|
+$933K |
| 5 |
Novartis
NVS
|
+$796K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 21.12% |
| 3 | Industrials | 16.32% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Communication Services | 11.81% |
Similar funds
PLU
RR
TAIM
KGAMU
GPWA
MAC
BT
IC
Chad R. Baker's Q2 2021 Portfolio in Review
As of Q2 2021, Chad R. Baker held 54 positions worth $445M, up 6.6% from $417M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Chad R. Baker's Q2 2021 filing shows 1 new, 5 reduced and 3 closed positions. Its largest new stake was Medtronic: 37,550 shares worth $4.66M. The largest sale was Fiserv Inc, an estimated $3.38M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- Chad R. Baker's largest Q2 2021 buy was Medtronic: 37,550 shares worth $4.66M.
- Chad R. Baker's biggest Q2 2021 reduction was Fiserv Inc, cutting an estimated $3.38M.
- Chad R. Baker fully exited International Flavors & Fragrances in Q2 2021, selling an estimated $1.4M.
- Chad R. Baker's ten largest holdings make up 42% of its $445M portfolio in Q2 2021.
- Chad R. Baker opened 1 new position and closed 3 in Q2 2021.
- Chad R. Baker's portfolio value rose 6.6% quarter-over-quarter to $445M.
Based on Chad R. Baker's 13F filing for Q2 2021, filed 4 Aug 2021.